(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)methanol, 95.0%, 25g

N-(2-chloroacetyl)-2-methoxybenzamide, 97%, 1g

2-desoxi-D-glucosa, mínimo 98 %, para bioquímica, 50 mg, envase de vidrio

(R)-2-(2-((tert-Butoxycarbonyl)amino)-2-methylpropanamido)-3-(1H-indol-3-yl)propanoic acid, 98%, 5g

Chloro-o-xylene (mixture of 3- and 4-isomers)>97.0%(GC)500g

(2-Methoxy-5-methylpyridin-3-yl)boronic acid, 95.0%, 250mg

(S)-2-((((Benzyloxy)carbonyl)amino)methyl)-3-methylbutanoic acid, 97%, 100mg

(R)-5-Amino-2-(((benzyloxy)carbonyl)(trityl)amino)-5-oxopentanoic acid, 97%, 25g

(2-Amino-4-chlorophenyl)methanol, 95.0%, 5g

Cyanopyrazine>99.0%(GC)500g

BENZYL 3-CARBAMOYLPYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

(5-Chloro-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-6'-yl)methanol (Etoricoxib Impurity), 97%, 50mg

Zinc acetate dihydrate, 98.0%, 100g